Basic Information
| RNALocate ID: | RLID-D:11000188 |
| RNA Symbol: | hsa-miR-140-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-140-3p |
| RNA ID: | miRBase:MIMAT0004597 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Blood|B lymphoblastoid cells|Breast milk|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002602 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002603 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11003737 | Exosome | HCC tissues | 30542726 |
| RLID:11003738 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003739 | Exosome | Breast milk | 22211110 |
| RLID:11003740 | Exosome | Plasma | 23663360 |
| RLID:11003741 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11003742 | Microvesicle | Plasma | 23077538 |
| RLID:11003743 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11003744 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11003745 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000627 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-140-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-13384 |
| MNDR | hsa-miR-140-3p | Oral squamous cell carcinoma | MNDR-E-MI-13385 |
| MNDR | hsa-miR-140-3p | Large cell neuroendocrine cancer | MNDR-E-MI-13386 |
| MNDR | hsa-miR-140-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-13387 |
| MNDR | hsa-miR-140-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-13388 |
| MNDR | hsa-miR-140-3p | Lymphoma | MNDR-E-MI-13389 |
| MNDR | hsa-miR-140-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-13390 |
| MNDR | hsa-miR-140-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-13391 |
| MNDR | hsa-miR-140-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-13392 |
| MNDR | hsa-miR-140-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-13393 |
| MNDR | hsa-miR-140-3p | Her2-receptor positive breast cancer | MNDR-E-MI-13394 |
| MNDR | hsa-miR-140-3p | Breast cancer luminal | MNDR-E-MI-13395 |
| MNDR | hsa-miR-140-3p | Prostate cancer | MNDR-E-MI-13396 |
| MNDR | hsa-miR-140-3p | Gastric cancer | MNDR-E-MI-13397 |
| MNDR | hsa-miR-140-3p | Alzheimer disease | MNDR-E-MI-13398 |
| MNDR | hsa-miR-140-3p | Intracranial aneurysm | MNDR-E-MI-13399 |
| MNDR | hsa-miR-140-3p | Bladder cancer | MNDR-E-MI-13400 |
| MNDR | hsa-miR-140-3p | Esophageal carcinoma | MNDR-E-MI-13401 |
| MNDR | hsa-miR-140-3p | Dysautonomia familial | MNDR-E-MI-13402 |
| MNDR | hsa-miR-140-3p | Myotonic dystrophy | MNDR-E-MI-13403 |
| MNDR | hsa-miR-140-3p | Malaria | MNDR-E-MI-13404 |
| MNDR | hsa-miR-140-3p | Leukemia | MNDR-E-MI-13405 |
| MNDR | hsa-miR-140-3p | Huntington disease | MNDR-E-MI-13406 |
| MNDR | hsa-miR-140-3p | Chorea | MNDR-E-MI-13407 |
| MNDR | hsa-miR-140-3p | Cardiovascular disease | MNDR-E-MI-13408 |
| MNDR | hsa-miR-140-3p | Moyamoya disease | MNDR-E-MI-13409 |
| MNDR | hsa-miR-140-3p | Lung cancer | MNDR-E-MI-13410 |
| MNDR | hsa-miR-140-3p | Biliary atresia | MNDR-E-MI-13411 |
| MNDR | hsa-miR-140-3p | Parkinson disease | MNDR-E-MI-13412 |
| MNDR | hsa-miR-140-3p | Basal-like breast cancer | MNDR-E-MI-13413 |
| MNDR | hsa-miR-140-3p | Pancreatic cancer | MNDR-E-MI-13414 |
| MNDR | hsa-miR-140-3p | Melanoma | MNDR-E-MI-13415 |
| MNDR | hsa-miR-140-3p | Rectum adenocarcinoma | MNDR-E-MI-13416 |
| MNDR | hsa-miR-140-3p | Nephroblastoma | MNDR-E-MI-13417 |
| MNDR | hsa-miR-140-3p | Ischemic attack transient | MNDR-E-MI-13418 |
| MNDR | hsa-miR-140-3p | Colon adenocarcinoma | MNDR-E-MI-13419 |
| MNDR | hsa-miR-140-3p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-13420 |
| MNDR | hsa-miR-140-3p | Familial ovarian cancer | MNDR-E-MI-13421 |
| MNDR | hsa-miR-140-3p | Basal cell carcinoma | MNDR-E-MI-13422 |
| MNDR | hsa-miR-140-3p | Carcinoma ductal breast | MNDR-E-MI-13423 |
| MNDR | hsa-miR-140-3p | Invasive ductal carcinoma | MNDR-E-MI-13424 |
| MNDR | hsa-miR-140-3p | Glioblastoma | MNDR-E-MI-13425 |
| MNDR | hsa-miR-140-3p | Glioma | MNDR-E-MI-13426 |
| MNDR | hsa-miR-140-3p | Chordoma | MNDR-E-MI-13427 |
| MNDR | hsa-miR-140-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-13428 |
| MNDR | hsa-miR-140-3p | Epilepsy temporal lobe | MNDR-E-MI-13429 |
| MNDR | hsa-miR-140-3p | Osteosarcoma | MNDR-E-MI-13430 |
| MNDR | hsa-miR-140-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-13431 |
| MNDR | hsa-miR-140-3p | Meningioma | MNDR-E-MI-13432 |
| MNDR | hsa-miR-140-3p | Gastric adenocarcinoma | MNDR-E-MI-13433 |
| MNDR | hsa-miR-140-3p | Cervical squamous cell carcinoma | MNDR-E-MI-13434 |
| MNDR | hsa-miR-140-3p | Lung squamous cell carcinoma | MNDR-E-MI-13435 |
| MNDR | hsa-miR-140-3p | Carcinoma lung non-small-cell | MNDR-E-MI-13436 |
| MNDR | hsa-miR-140-3p | Lung adenocarcinoma | MNDR-E-MI-13437 |
| MNDR | hsa-miR-140-3p | Thyroid carcinoma | MNDR-E-MI-13438 |
| MNDR | hsa-miR-140-3p | Ovarian carcinoma | MNDR-E-MI-13439 |
| MNDR | hsa-miR-140-3p | Bladder urothelial carcinoma | MNDR-E-MI-13440 |
| MNDR | hsa-miR-140-3p | Brain stem cancer | MNDR-E-MI-13441 |
| MNDR | hsa-miR-140-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-13442 |
| MNDR | hsa-miR-140-3p | Carcinoma renal cell | MNDR-E-MI-13443 |
| MNDR | hsa-miR-140-3p | Renal clear cell carcinoma | MNDR-E-MI-13444 |
| MNDR | hsa-miR-140-3p | Cholangiocarcinoma | MNDR-E-MI-13445 |
| MNDR | hsa-miR-140-3p | Lung small cell carcinoma | MNDR-E-MI-13446 |
| MNDR | hsa-miR-140-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-13447 |
| MNDR | hsa-miR-140-3p | Breast invasive carcinoma | MNDR-E-MI-13448 |
| MNDR | hsa-miR-140-3p | Hepatocellular carcinoma | MNDR-E-MI-13449 |
| MNDR | hsa-miR-140-3p | Familiar ovarian carcinoma | MNDR-E-MI-13450 |
| MNDR | hsa-miR-140-3p | B-cell lymphoma | MNDR-E-MI-13451 |
| MNDR | hsa-miR-140-3p | Rheumatoid arthritis | MNDR-E-MI-13452 |
| MNDR | hsa-miR-140-3p | Retinoblastoma | MNDR-E-MI-13453 |
| MNDR | hsa-miR-140-3p | Neuromyelitis optica | MNDR-E-MI-13454 |
| MNDR | hsa-miR-140-3p | Skin cutaneous melanoma | MNDR-E-MI-13455 |
| MNDR | hsa-miR-140-3p | Skin melanoma | MNDR-E-MI-13456 |
| MNDR | hsa-miR-140-3p | Colorectal cancer | MNDR-E-MI-13457 |
| MNDR | hsa-miR-140-3p | Nasopharynx carcinoma | MNDR-E-MI-13458 |
| MNDR | hsa-miR-140-3p | Multiple myeloma | MNDR-E-MI-13459 |
| MNDR | hsa-miR-140-3p | Nasopharyngeal cancer | MNDR-E-MI-13460 |
| MNDR | hsa-miR-140-3p | Hypersomnolence idiopathic | MNDR-E-MI-13461 |
| MNDR | hsa-miR-140-3p | Stroke lacunar | MNDR-E-MI-13462 |
| MNDR | hsa-miR-140-3p | Breast cancer her3+ negative | MNDR-E-MI-13463 |
| MNDR | hsa-miR-140-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-13464 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ATP6AP2 | Homo sapiens | RR00162571 |
TOP